| Code | 0936E | ||||||||||
| MA number | 16/0150/22-S | ||||||||||
| Product Form: | tbl flm 100x20 mg (fľ.HDPE) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | CANDE s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 24.05.2022 |
| Validity: | 24.05.2027 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| SPC: |
SPC_RIVAMED 20 mg_11.2024.pdf
|
| PIL: |
PIL_RIVAMED 15 mg_20 mg_11.2024.pdf
|
| Dokument: |
Rivaroxabán_Príručka pre predpisujúceho lekára.pdf
|
| Safety feature | Yes |
| Data update: | 24.05.2022 |
